Minocycline inhibits brain inflammation and attenuates spontaneous recurrent seizures following pilocarpine-induced status epilepticus

Neuroscience

Volumn 287, Issue , 2015, Pages 144-156

  Wang, N ^a,b   Mi, X ^a,b   Gao, B ^a,b   Gu, J ^a,b   Wang, W ^a,b   Zhang, Y ^a,b   Wang, X ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Chongqing Key Laboratory of Cytomics   (China)

Author keywords

Astrocytes; Cytokine; Epileptogenesis; Microglia; Minocycline

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; LITHIUM; MINOCYCLINE; PILOCARPINE; TUMOR NECROSIS FACTOR ALPHA; ANTICONVULSIVE AGENT; ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN PROTECTION; CELL ACTIVATION; CELL LOSS; CYTOKINE PRODUCTION; ENCEPHALITIS; EPILEPTIC STATE; HIPPOCAMPAL CA1 REGION; MICROGLIA; NONHUMAN; RAT; RECURRENT DISEASE; SEIZURE; TEMPORAL LOBE EPILEPSY; VIDEORECORDING; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; GLIA; HIPPOCAMPUS; MALE; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTICONVULSANTS; CEREBRAL CORTEX; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; EPILEPSY, TEMPORAL LOBE; HIPPOCAMPUS; MALE; MINOCYCLINE; NEUROGLIA; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; STATUS EPILEPTICUS;

EID: 84920972425     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.12.021     Document Type: Article

References (64)

1. Abraham J., Fox P.D., Condello C., Bartolini A., Koh S. Minocycline attenuates microglia activation and blocks the long-term epileptogenic effects of early-life seizures. Neurobiol Dis 2012, 46:425-430.
2. Ahmadirad N., Shojaei A., Javan M., Pourgholami M.H., Mirnajafi-Zadeh J. Effect of minocycline on pentylenetetrazol-induced chemical kindled seizures in mice. Neurol Sci 2013.
3. Andre V., Rigoulot M.A., Koning E., Ferrandon A., Nehlig A. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. Epilepsia 2003, 44:893-903.
4. Aronica E., Gorter J.A., Redeker S., Ramkema M., Spliet W.G., van Rijen P.C., Leenstra S., Troost D. Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy. Neuropathol Appl Neurobiol 2005, 31:280-291.
5. Auvin S., Shin D., Mazarati A., Sankar R. Inflammation induced by LPS enhances epileptogenesis in immature rat and may be partially reversed by IL1RA. Epilepsia 2010, 51(Suppl. 3):34-38.
6. Beach T.G., Woodhurst W.B., MacDonald D.B., Jones M.W. Reactive microglia in hippocampal sclerosis associated with human temporal lobe epilepsy. Neurosci Lett 1995, 191:27-30.
7. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFalpha. Science (New York, NY) 2002, 295:2282-2285.
8. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69.
9. Boer K., Spliet W.G., van Rijen P.C., Redeker S., Troost D., Aronica E. Evidence of activated microglia in focal cortical dysplasia. J Neuroimmunol 2006, 173:188-195.
10. Brandt C., Nozadze M., Heuchert N., Rattka M., Loscher W. Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy. J Neurosci 2010, 30:8602-8612.
11. Caggiano A.O., Kraig R.P. Eicosanoids and nitric oxide influence induction of reactive gliosis from spreading depression in microglia but not astrocytes. J Comp Neurol 1996, 369:93-108.
12. Chu K., Jung K.H., Lee S.T., Kim J.H., Kang K.M., Kim H.K., Lim J.S., Park H.K., Kim M., Lee S.K., Roh J.K. Erythropoietin reduces epileptogenic processes following status epilepticus. Epilepsia 2008, 49:1723-1732.
13. de Lanerolle N.C., Lee T.S., Spencer D.D. Astrocytes and epilepsy. Neurotherapeutics 2010, 7:424-438.
14. De Simoni M.G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S., Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci 2000, 12:2623-2633.
15. Devinsky O., Vezzani A., Najjar S., De Lanerolle N.C., Rogawski M.A. Glia and epilepsy: excitability and inflammation. Trends Neurosci 2013, 36:174-184.
16. Eid T., Williamson A., Lee T.S., Petroff O.A., de Lanerolle N.C. Glutamate and astrocytes-key players in human mesial temporal lobe epilepsy?. Epilepsia 2008, 49(Suppl. 2):42-52.
17. Francois J., Koning E., Ferrandon A., Nehlig A. The combination of topiramate and diazepam is partially neuroprotective in the hippocampus but not antiepileptogenic in the lithium-pilocarpine model of temporal lobe epilepsy. Epilepsy Res 2006, 72:147-163.
18. Garrido-Mesa N., Zarzuelo A., Galvez J. What is behind the non-antibiotic properties of minocycline?. Pharmacol Res 2013, 67:18-30.
19. Gibbons M.B., Smeal R.M., Takahashi D.K., Vargas J.R., Wilcox K.S. Contributions of astrocytes to epileptogenesis following status epilepticus: opportunities for preventive therapy?. Neurochem Int 2013, 63:660-669.
20. Hitiris N., Brodie M.J. Modern antiepileptic drugs: guidelines and beyond. Curr Opin Neurol 2006, 19:175-180.
21. Hu S., Sheng W.S., Ehrlich L.C., Peterson P.K., Chao C.C. Cytokine effects on glutamate uptake by human astrocytes. NeuroImmunoModulation 2000, 7:153-159.
22. Jiang G., Cao Q., Li J., Zhang Y., Liu X., Wang Z., Guo F., Chen Y., Chen G., Wang X. Altered expression of vesicular monoamine transporter 2 in epileptic patients and experimental rats. Synapse (New York, NY) 2013, 67:415-426.
23. Jung K.H., Chu K., Lee S.T., Kim J., Sinn D.I., Kim J.M., Park D.K., Lee J.J., Kim S.U., Kim M., Lee S.K., Roh J.K. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol Dis 2006, 23:237-246.
24. Kielian T., Esen N., Liu S., Phulwani N.K., Syed M.M., Phillips N., Nishina K., Cheung A.L., Schwartzman J.D., Ruhe J.J. Minocycline modulates neuroinflammation independently of its antimicrobial activity in staphylococcus aureus-induced brain abscess. Am J Pathol 2007, 171:1199-1214.
25. Kim H.S., Suh Y.H. Minocycline and neurodegenerative diseases. Behav Brain Res 2009, 196:168-179.
26. Linard B., Ferrandon A., Koning E., Nehlig A., Raffo E. Ketogenic diet exhibits neuroprotective effects in hippocampus but fails to prevent epileptogenesis in the lithium-pilocarpine model of mesial temporal lobe epilepsy in adult rats. Epilepsia 2010, 51:1829-1836.
27. Loscher W., Brandt C. Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 2010, 62:668-700.
28. Murashima Y.L., Suzuki J., Yoshii M. Role of cytokines during epileptogenesis and in the transition from the interictal to the ictal state in the epileptic mutant EL mouse. Gene Regul Syst Biol 2008, 2:267-274.
29. Nasr S.M., Moghimi A., Mohammad-Zadeh M., Shamsizadeh A., Noorbakhsh S.M. The effect of minocycline on seizures induced by amygdala kindling in rats. Seizure 2013, 22:670-674.
30. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2005, Academic Press, New York.
31. Pitkanen A. Therapeutic approaches to epileptogenesis-hope on the horizon. Epilepsia 2010, 51(Suppl. 3):2-17.
32. Pitkanen A., Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011, 10:173-186.
33. Pitkanen A., Sutula T.P. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 2002, 1:173-181.
34. Polascheck N., Bankstahl M., Loscher W. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp Neurol 2010, 224:219-233.
35. Popovic N., Schubart A., Goetz B.D., Zhang S.C., Linington C., Duncan I.D. Inhibition of autoimmune encephalomyelitis by a tetracycline. Ann Neurol 2002, 51:215-223.
36. Racine R.J. Modification of seizure activity by electrical stimulation. I. After-discharge threshold. Electroencephalogr Clin Neurophysiol 1972, 32:269-279.
37. Rao R.S., Medhi B., Saikia U.N., Arora S.K., Toor J.S., Khanduja K.L., Pandhi P. Experimentally induced various inflammatory models and seizure: understanding the role of cytokine in rat. Eur Neuropsychopharmacol 2008, 18:760-767.
38. Ravizza T., Gagliardi B., Noe F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008, 29:142-160.
39. Ravizza T., Noe F., Zardoni D., Vaghi V., Sifringer M., Vezzani A. Interleukin Converting Enzyme inhibition impairs kindling epileptogenesis in rats by blocking astrocytic IL-1beta production. Neurobiol Dis 2008, 31:327-333.
40. Ravizza T., Balosso S., Vezzani A. Inflammation and prevention of epileptogenesis. Neurosci Lett 2011, 497:223-230.
41. Saivin S., Houin G. Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet 1988, 15:355-366.
42. Shapiro L.A., Wang L., Ribak C.E. Rapid astrocyte and microglial activation following pilocarpine-induced seizures in rats. Epilepsia 2008, 49(Suppl. 2):33-41.
43. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 2005, 25:3219-3228.
44. Tikka T., Fiebich B.L., Goldsteins G., Keinanen R., Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 2001, 21:2580-2588.
45. Tikka T.M., Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol (Baltimore, Md: 1950) 2001, 166:7527-7533.
46. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., De Simoni M.G., Sperk G., Andell-Jonsson S., Lundkvist J., Iverfeldt K., Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc Natl Acad Sci U S A 2000, 97:11534-11539.
47. Vezzani A., Ravizza T., Balosso S., Aronica E. Glia as a source of cytokines: implications for neuronal excitability and survival. Epilepsia 2008, 49(Suppl. 2):24-32.
48. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat Rev Neurol 2011, 7:31-40.
49. Vezzani A., Aronica E., Mazarati A., Pittman Q.J. Epilepsy and brain inflammation. Exp Neurol 2013, 244:11-21.
50. Vezzani A., Friedman A., Dingledine R.J. The role of inflammation in epileptogenesis. Neuropharmacology 2013, 69:16-24.
51. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 2003, 23:8692-8700.
52. Wang S., Cheng Q., Malik S., Yang J. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J Pharmacol Exp Ther 2000, 292:497-504.
53. Wang D.D., Englot D.J., Garcia P.A., Lawton M.T., Young W.L. Minocycline- and tetracycline-class antibiotics are protective against partial seizures in vivo. Epilepsy Behav 2012, 24:314-318.
54. Wetherington J., Serrano G., Dingledine R. Astrocytes in the epileptic brain. Neuron 2008, 58:168-178.
55. Wu D.C., Jackson-Lewis V., Vila M., Tieu K., Teismann P., Vadseth C., Choi D.K., Ischiropoulos H., Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002, 22:1763-1771.
56. Xu Y., Zeng K., Han Y., Wang L., Chen D., Xi Z., Wang H., Wang X., Chen G. Altered expression of CX3CL1 in patients with epilepsy and in a rat model. Am J Pathol 2012, 180:1950-1962.
57. Xu D., Miller S.D., Koh S. Immune mechanisms in epileptogenesis. Front Cell Neurosci 2013, 7:195.
58. Yang F., Liu Z.R., Chen J., Zhang S.J., Quan Q.Y., Huang Y.G., Jiang W. Roles of astrocytes and microglia in seizure-induced aberrant neurogenesis in the hippocampus of adult rats. J Neurosci Res 2010, 88:519-529.
59. Yang D., Li Q., Fang L., Cheng K., Zhang R., Zheng P., Zhan Q., Qi Z., Zhong S., Xie P. Reduced neurogenesis and pre-synaptic dysfunction in the olfactory bulb of a rat model of depression. Neuroscience 2011, 192:609-618.
60. Yong V.W., Wells J., Giuliani F., Casha S., Power C., Metz L.M. The promise of minocycline in neurology. Lancet Neurol 2004, 3:744-751.
61. Yoon S.Y., Patel D., Dougherty P.M. Minocycline blocks lipopolysaccharide induced hyperalgesia by suppression of microglia but not astrocytes. Neuroscience 2012, 221:214-224.
62. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 1998, 95:15769-15774.
63. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci U S A 1999, 96:13496-13500.
64. Zheng H., Zhu W., Zhao H., Wang X., Wang W., Li Z. Kainic acid-activated microglia mediate increased excitability of rat hippocampal neurons in vitro and in vivo: crucial role of interleukin-1beta. NeuroImmunoModulation 2010, 17:31-38.